The TIF 2.0 procedure enables an incisionless approach to fundoplication in which a device is inserted through the mouth, down the esophagus and into the upper portion of the stomach. This approach ...
REDMOND, Wa.--(BUSINESS WIRE)--EndoGastric Solutions, Inc.® today announced that the American Gastroenterology Association retired their 2008 guidelines, Management of Gastroesophageal Reflux Disease ...
A meta-analysis in Chirugia found that the Transoral Incisionless Fundoplication 2.0 procedure is an appropriate treatment for refractory gastroesophageal reflux disease. 1. The TIF 2.0 procedure is a ...
EndoGastric Solutions will present new data on the company’s Transoral Incisionless Fundoplication procedure for the treatment of gastroesophageal reflux disease at the Digestive Disease Week 2016 ...
The TIF procedure is safe and effective in eliminating or improving a range of typical and atypical gastroesophageal reflux disease (GERD) symptoms, including heartburn and reflux, in up to 81 percent ...
SOUTH JORDAN, Utah, March 27, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the American Society for ...
Setting the tone for the biopharma industry as it enters a new year, the J.P. Morgan Healthcare Conference (JPM) held each January has once again led to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results